首页> 外国专利> PREVENTION OF OSTEOPOROSIS AND REMEDY FOR OSTEOPOROSIS

PREVENTION OF OSTEOPOROSIS AND REMEDY FOR OSTEOPOROSIS

机译:骨质疏松症的预防和骨质疏松症的补救措施

摘要

PURPOSE:To obtain the subject formulation containing imidazo-[4,5-C] quinoline-4-one derivative or acid-added salt of said derivative as an active ingredient. CONSTITUTION:The subject formulation contains a compound expressed by the formula or pharmacologically allowable acid-added salt of the compound (R1 is H or lower alkyl; R2 is H, OH or SH; R3 is lower alkyl or lower alkoxyalkyl). The compound expressed by the formula has excellent bone resorption activity and is useful for prevention and curing of osteoporosis. The compound expressed by the formula or acid-added salt of the compound is uniformly mixed with a carrier and prepared to an unit taking shape suitable for administration by per as such as tablet or capsule, or injection. Administration dose of the compound expressed by the formula is usually 20-100mg/person per 1 day.
机译:目的:获得包含咪唑并[4,5-C]喹啉-4-酮衍生物或该衍生物的加酸盐作为有效成分的主题制剂。组成:本制剂含有下式表示的化合物或该化合物的药理学允许酸加成盐(R 1为H或低级烷基; R 2为H,OH或SH; R 3较低烷基或低级烷氧基烷基)。由该式表示的化合物具有优异的骨吸收活性,并且可用于预防和治疗骨质疏松症。将由通式表示的化合物或该化合物的加酸盐与载体均匀混合,并制备成适于通过例如片剂或胶囊剂或注射剂给药的形状的单元。由该式表示的化合物的给药剂量通常为20-100mg /人每1天。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号